Annual report pursuant to Section 13 and 15(d)

Acquisitions (Tables)

v3.22.1
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2021
Business Acquisition [Line Items]  
Schedule of pro forma financial information
 
Six Months Ended December 31,


Year Ended

June 30,




2020

2020

Revenue
$ 14,026

$ 27,523
Net loss
$ (17,650 )
$ (20,250 )
Trellis Solutions, Inc. [Member]  
Business Acquisition [Line Items]  
Schedule of estimated acquisition date fair value of consideration
Common shares issued $ 2,531
Contingent consideration
998
Total estimated fair value of consideration $ 3,529
Schedule of preliminary estimated fair values of assets acquired and liabilities
Cash   $ 21  
Accounts receivable, net     91  
Other assets

6
Acquired technology     210
 
Acquired trade name

80
Customer relationships

220
Goodwill

3,216
Accounts payable and accrued expenses     (284 )
Deferred revenue

(31 )
Net assets acquired   $ 3,529  
Solo Sciences, Inc. [Member]  
Business Acquisition [Line Items]  
Schedule of estimated acquisition date fair value of consideration
Common shares issued $ 17,550
Contingent consideration
389
Total estimated fair value of consideration $ 17,939
Schedule of preliminary estimated fair values of assets acquired and liabilities
Cash   $ 101  

Prepaid expenses and other assets

    22  
Furniture, fixtures, and equipment     2  
Acquired technology     7,160  

Acquired trade name



340
Goodwill     17,025
Accounts payable and accrued liabilities

(1,158 )
Fair value of noncontrolling interests     (5,553 )
Net assets acquired   $ 17,939  
Ample Organics [Member]  
Business Acquisition [Line Items]  
Schedule of estimated acquisition date fair value of consideration

 


Preliminary
Fair Value

 

Exchangeable shares issued

$

25,203

 

Cash


5,724

 

Contingent consideration


604

 

Total estimated fair value of consideration transferred

$

31,531

 

Schedule of preliminary estimated fair values of assets acquired and liabilities

 

Preliminary
Fair Value

 

Cash

$

445

 

Accounts receivable

 

917

 

Prepaid expenses and other current assets

 

595

 

Acquired technology

 

850

 

Customer relationships

 

2,660

 

Acquired trade name

 

285

 

Goodwill

 

25,806

 

Furniture, fixtures and equipment

 

1,327

 

Accounts payable and accrued expenses

 

(805

)

Deferred revenue

 

(549

)

Net assets acquired

$

31,531

 

Viridian Sciences Inc. [Member]  
Business Acquisition [Line Items]  
Schedule of estimated acquisition date fair value of consideration

 

 

Preliminary
Fair Value

 

Shares issued

 

$

6,186

 

Contingent consideration

2
Total preliminary fair value of consideration transferred
$ 6,188
Schedule of preliminary estimated fair values of assets acquired and liabilities

 

 

Preliminary
Fair Value

 

Accounts receivable

 

 

556

 

Prepaid expenses and other current assets

 

 

148

 

Capitalized software

423

Acquired technology

 

 

470

 

Customer relationships

820
Acquired trade name

20
Goodwill

5,408

Accounts payable and accrued expenses

 

 

(350

)
Deferred tax liabilities

(307 )

Deferred revenue

 

 

(1,000

)

Net assets acquired

 

$

6,188

 

365 Cannabis [Member]  
Business Acquisition [Line Items]  
Schedule of estimated acquisition date fair value of consideration

 

 

Preliminary
Fair Value

 

Shares issued

 

$

12,000

 

Cash

5,542
Contingent consideration

6,300
Total preliminary fair value of consideration transferred
$ 23,842
Schedule of preliminary estimated fair values of assets acquired and liabilities

 

 

Preliminary
Fair Value

 

Cash

527
Accounts receivable

 

 

486

 

Prepaid expenses and other current asset

261
Fixed Assets

93
Non-compete agreement

80

Acquired technology

 

 

1,040

 

Customer relationships

13,810
Acquired trade name

270
Goodwill

14,043

Accounts payable and accrued expenses

 

 

(826

)
Deferred tax liabilities

(2,642 )

Deferred revenue

 

 

(3,300

)

Net assets acquired

 

$

23,842